Hester Biosciences Limited (BOM:524669)

Hester Biosciences Revenue

In the fiscal year ending March 31, 2026, Hester Biosciences had annual revenue of 3.33B INR with 6.44% growth. Hester Biosciences had revenue of 1.00B in the quarter ending March 31, 2026, with 38.23% growth.

• Revenue: 3.33B
• Revenue Growth: +6.44%
• P/S Ratio: 5.00
• Revenue / Employee: 5.92M
• Employees: 562
• Market Cap: 16.63B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	3.33B	201.25M	6.44%
Mar 31, 2025	3.12B	12.80M	0.41%
Mar 31, 2024	3.11B	329.89M	11.86%
Mar 31, 2023	2.78B	315.58M	12.79%
Mar 31, 2022	2.47B	289.51M	13.30%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 1, 2026

Data Sources Report a data error